Introduction: Autologous CAR T-cell therapies have been transformative in the treatment of selected blood cancers. Despite this remarkable success, long term studies on patients treated with CD19 or CD22 T-cells revealed emergence relapses often due to antigen loss. The therapeutic options after are limited, underscoring urgent need develop novel improve current survival rates. In addition, the...

Background: Diabetic nephropathy (DN) continues to be the leading cause of end-stage renal disease (ESRD) worldwide, and increased amount evidence supports that inflammation plays an important role in DN progression. Aim: Therefore, we aimed explore relationships between tubulointerstitial inflammatory cells infiltration kidney prognosis patients. Method: A total 384 Chinese participants with t...